Evidence map›Paper›PMID 36440953›Full record

Trial reportHuman brain mapping2023

The relevance of rich club regions for functional outcome post-stroke is enhanced in women.

Anna K Bonkhoff, Markus D Schirmer, Martin Bretzner, Sungmin Hong, Robert W Regenhardt, Kathleen L Donahue, Marco J Nardin, Adrian V Dalca, Anne-Katrin Giese, Mark R Etherton and 42 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Human brain mapping, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

52 authors.

Anna K BonkhoffJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-5927-1089
Markus D SchirmerJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Martin BretznerJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Sungmin HongJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Robert W RegenhardtJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kathleen L DonahueJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marco J NardinJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Adrian V DalcaComputer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, Boston, Massachusetts, USA.
Anne-Katrin GieseDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mark R EthertonJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Brandon L HancockAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Steven J T MockingAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Elissa C McIntoshDepartment of Psychiatry, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
John AttiaHunter Medical Research Institute, Newcastle, New South Wales, Australia.
John W ColeDepartment of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USA.
Amanda DonattiSchool of Medical Sciences, University of Campinas (UNICAMP) and the Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), Campinas, São Paulo, Brazil.
Christoph J GriessenauerDepartment of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.
Laura HeitschDepartment of Emergency Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Lukas HolmegaardDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Katarina JoodDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jordi Jimenez-CondeDepartment of Neurology, Neurovascular Research Group (NEUVAS), IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques). Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona, Spain.
Steven J KittnerDepartment of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USA.
Robin LemmensDepartment of Neurosciences, KU Leuven - University of Leuven, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), Leuven, Belgium.
Christopher R LeviSchool of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
Caitrin W McDonoughDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, Florida, USA.
James F MeschiaDepartment of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
Chia-Ling PhuahDepartment of Neurology, Washington University School of Medicine & Barnes-Jewish Hospital, St Louis, Missouri, USA.
Stefan RopeleDepartment of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Graz, Austria.
Jonathan RosandJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jaume RoquerDepartment of Neurology, Neurovascular Research Group (NEUVAS), IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques). Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona, Spain.
Tatjana RundekDepartment of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Ralph L SaccoDepartment of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Reinhold SchmidtDepartment of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Graz, Austria.
Pankaj SharmaInstitute of Cardiovascular Research, Royal Holloway University of London (ICR2UL), Egham, UK.
Agnieszka SlowikDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Alessandro SousaSchool of Medical Sciences, University of Campinas (UNICAMP) and the Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), Campinas, São Paulo, Brazil.
Tara M StanneDepartment of Laboratory Medicine, Institute of Biomedicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Daniel StrbianDepartment of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Turgut TatlisumakDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Vincent ThijsStroke Division, Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
Achala VagalDepartment of Radiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Johan WasseliusDepartment of Clinical Sciences Lund, Radiology, Lund University, Lund, Sweden.
Daniel WooDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Ramin ZandDepartment of Neurology, Pennsylvania State University, Hershey, Pennsylvania, USA.
Patrick F McArdleDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Bradford B WorrallDepartments of Neurology and Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Christina JernDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Arne G LindgrenDepartment of Neurology, Skåne University Hospital, Lund, Sweden.
Jane MaguireUniversity of Technology Sydney, Sydney, Australia.
Ona WuAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Natalia S RostJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
MRI-GENIE and GISCOME Investigators and the International Stroke Genetics Consortium

Funding

DISCOVERY - Statistics and Analysis CoreU19NS115388 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Steven M Greenberg, Natalia S Rost · 2019 to 2026
$75.4M
Making Acute Stroke Trials Succeed: Challenges and Potential SolutionsU01NS110772 · NINDS · UNIVERSITY OF CINCINNATI · PI Joseph Paul Broderick, Jordan J. Elm · 2020 to 2026
$24.3M
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke TrialU01NS100699 · NINDS · WASHINGTON UNIVERSITY · PI ADEOYE, OPEOLU M, BARRETO, ANDREW D · 2018 to 2021
$18.8M
ICH Recovery GrantR01NS100417 · NINDS · UNIVERSITY OF CINCINNATI · PI WOO, DANIEL · 2017 to 2021
$5.3M
MRI-GENetics Interface Exploration_MRI-GENIE_StudyR01NS086905 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROST, NATALIA S · 2015 to 2019
$3.3M
Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) StudyR01NS103824 · NINDS · UNIVERSITY OF CINCINNATI · PI KHATRI, POOJA, KISSELA, BRETT M · 2018 to 2022
$3.1M
Statins augment small vessel function and improve stroke outcomesR01NS082285 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROST, NATALIA S · 2013 to 2017
$2.6M
CNV And Stroke (CaNVAS)R01NS114045 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI COLE, JOHN W. · 2020 to 2024
$2.6M
APRISE Dementia (Assessing Population-based Radiological brain health in Stroke Epidemiology-Dementia)RF1NS117643 · NINDS · UNIVERSITY OF CINCINNATI · PI KHATRI, POOJA, KISSELA, BRETT M · 2020 to 2020
$2.0M
NINDS NIH HHS R01 NS082285NINDS NIH HHS R01 NS086905NINDS NIH HHS R01 NS100417NINDS NIH HHS R01 NS103824NINDS NIH HHS R01 NS114045NINDS NIH HHS RF1 NS117643NINDS NIH HHS U01 NS100699NINDS NIH HHS U01 NS110772NINDS NIH HHS U19 NS115388
6 · The paper itself

Abstract

This study aimed to investigate the influence of stroke lesions in predefined highly interconnected (rich-club) brain regions on functional outcome post-stroke, determine their spatial specificity and explore the effects of biological sex on their relevance. We analyzed MRI data recorded at index stroke and ~3-months modified Rankin Scale (mRS) data from patients with acute ischemic stroke enrolled in the multisite MRI-GENIE study. Spatially normalized structural stroke lesions were parcellated into 108 atlas-defined bilateral (sub)cortical brain regions. Unfavorable outcome (mRS > 2) was modeled in a Bayesian logistic regression framework. Effects of individual brain regions were captured as two compound effects for (i) six bilateral rich club and (ii) all further non-rich club regions. In spatial specificity analyses, we randomized the split into "rich club" and "non-rich club" regions and compared the effect of the actual rich club regions to the distribution of effects from 1000 combinations of six random regions. In sex-specific analyses, we introduced an additional hierarchical level in our model structure to compare male and female-specific rich club effects. A total of 822 patients (age: 64.7[15.0], 39% women) were analyzed. Rich club regions had substantial relevance in explaining unfavorable functional outcome (mean of posterior distribution: 0.08, area under the curve: 0.8). In particular, the rich club-combination had a higher relevance than 98.4% of random constellations. Rich club regions were substantially more important in explaining long-term outcome in women than in men. All in all, lesions in rich club regions were associated with increased odds of unfavorable outcome. These effects were spatially specific and more pronounced in women.

Indexed as

Ischemic StrokeStrokeBayes TheoremBrainFemaleHumansMaleMiddle AgedModels, NeurologicalBayesian hierarchical modelingfunctional outcomelesion-symptom mappingrich clubsex differences

Identifiers

PMID36440953
PMCPMC9921242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.